Nouvelles en surbrillance
Australia now accepting applications for medical cannabis production
Canadian medical cannabis producers are expected to be among those to apply to produce cannabis crops for medical and scientific purposes. Australia’s Office of Drug Control begins accepting applications from private business for cannabis cultivation…
Advantages of the CBD-rich strains
At this stage, we are pretty sure that most of you have enough information to give a conference about THC, on its properties and its effects. But, what about CBD? Cannabidiol is the second cannabinoid…
Cannabis and lung health: a two-sided issue
How does smoking – the most popular form of cannabis administration – affect lung function? How does smoking – the most popular form of cannabis administration – affect lung function? Coughing, a common symptom of…
Cannabis use for sciatica & chronic low back pain
Low back pain is a common condition affecting many individuals at some point in their lives. [1] The estimation is that between 5.0% and 10.0% of cases will develop chronic low back pain (CLBP), which is…
NORML Releases Gubernatorial Report Card: Learn Where Your Governor Stands On Marijuana Policy
by Danielle Keane, NORML Political Director With the 2016 election only days away, NORML is pleased today to release of our first ever Gubernatorial Scorecard. Inspired by NORML’s Congressional Scorecard, this extensive database assigns a…
Damian Marley will transform a prison into a marijuana manufacturing plant
Poetic justice. Once again, marijuana and Reggae partner together. What has until now be a prison will house a space for legal cultivation. Sure some of the former prisoners would never have dreamed of such an…
Turkey legalises cannabis production for scientific purposes
Many countries around the world struggle to implement pro-cannabis regulations, such as Morocco, Germany and some USA states. Turkey has already taken a step forward. The Turkish Ministry of Food, Agriculture and Livestock has approved…
Cannabidiol improves severe form of childhood epilepsy in controlled clinical trial
The manufacturer of the CBD extract Epidiolex, GW Pharmaceuticals, reported of positive results of the second placebo-controlled Phase 3 clinical trial of this preparation for the treatment of seizures associated with Lennox-Gastaut syndrome, a rare…